These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30372685)

  • 1. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.
    Kempuraj D; Selvakumar GP; Thangavel R; Ahmed ME; Zaheer S; Kumar KK; Yelam A; Kaur H; Dubova I; Raikwar SP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 66(3):1117-1129. PubMed ID: 30372685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.
    Kempuraj D; Thangavel R; Selvakumar GP; Ahmed ME; Zaheer S; Raikwar SP; Zahoor H; Saeed D; Dubova I; Giler G; Herr S; Iyer SS; Zaheer A
    Mol Neurobiol; 2019 Mar; 56(3):1681-1693. PubMed ID: 29916143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.
    Kempuraj D; Thangavel R; Yang E; Pattani S; Zaheer S; Santillan DA; Santillan MK; Zaheer A
    PLoS One; 2015; 10(8):e0135776. PubMed ID: 26275153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease.
    Kempuraj D; Selvakumar GP; Zaheer S; Thangavel R; Ahmed ME; Raikwar S; Govindarajan R; Iyer S; Zaheer A
    J Neuroimmune Pharmacol; 2018 Mar; 13(1):100-112. PubMed ID: 28952015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)).
    Kempuraj D; Thangavel R; Fattal R; Pattani S; Yang E; Zaheer S; Santillan DA; Santillan MK; Zaheer A
    Neurochem Res; 2016 May; 41(5):1042-9. PubMed ID: 26646004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
    Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neurons.
    Khan MM; Zaheer S; Nehman J; Zaheer A
    Neuroscience; 2014 Sep; 277():196-205. PubMed ID: 25016212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.
    Khan MM; Kempuraj D; Zaheer S; Zaheer A
    J Mol Neurosci; 2014 Aug; 53(4):590-9. PubMed ID: 24430624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.
    Khan MM; Zaheer S; Thangavel R; Patel M; Kempuraj D; Zaheer A
    Neurochem Res; 2015 May; 40(5):980-90. PubMed ID: 25754447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.
    Hong GU; Cho JW; Kim SY; Shin JH; Ro JY
    Toxicol Appl Pharmacol; 2018 Nov; 358():10-22. PubMed ID: 30195017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Association of Glia Maturation Factor with the Autophagic Machinery in Rat Dopaminergic Neurons: a Role for Endoplasmic Reticulum Stress and MAPK Activation.
    Selvakumar GP; Iyer SS; Kempuraj D; Ahmed ME; Thangavel R; Dubova I; Raikwar SP; Zaheer S; Zaheer A
    Mol Neurobiol; 2019 Jun; 56(6):3865-3881. PubMed ID: 30218400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases.
    Kempuraj D; Khan MM; Thangavel R; Xiong Z; Yang E; Zaheer A
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):643-50. PubMed ID: 23397250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation Mediated by Glia Maturation Factor Exacerbates Neuronal Injury in an
    Ahmed ME; Selvakumar GP; Kempuraj D; Raikwar SP; Thangavel R; Bazley K; Wu K; Khan O; Kukulka K; Bussinger B; Dubova I; Zaheer S; Govindarajan R; Iyer S; Burton C; James D; Zaheer A
    J Neurotrauma; 2020 Jul; 37(14):1645-1655. PubMed ID: 32200671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury.
    Ahmed ME; Selvakumar GP; Kempuraj D; Raikwar SP; Thangavel R; Bazley K; Wu K; Khan O; Khan A; Zaheer S; Iyer S; Burton C; James D; Zaheer A
    Mol Neurobiol; 2020 Nov; 57(11):4438-4450. PubMed ID: 32737763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines.
    Zaheer A; Zaheer S; Sahu SK; Knight S; Khosravi H; Mathur SN; Lim R
    J Neurochem; 2007 Apr; 101(2):364-76. PubMed ID: 17250654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation Induces Neurodegeneration.
    Kempuraj D; Thangavel R; Natteru PA; Selvakumar GP; Saeed D; Zahoor H; Zaheer S; Iyer SS; Zaheer A
    J Neurol Neurosurg Spine; 2016; 1(1):. PubMed ID: 28127589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
    Kempuraj D; Thangavel R; Selvakumar GP; Zaheer S; Ahmed ME; Raikwar SP; Zahoor H; Saeed D; Natteru PA; Iyer S; Zaheer A
    Front Cell Neurosci; 2017; 11():216. PubMed ID: 28790893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.